Eric Topol

I had about 50 people, and they just said, you know what?

Yeah, we are the world leaders in genomics.

We want to be the world leader in AI.

Now, these days, you only hear about US and China, which is ridiculous.

And you have perhaps one of the

I would say most formidable groups there with Demis and Google Deep completely.

Just extraordinary.

So all the things that you, the main foci of the Ellison Institute,

Yeah, well, that's another reason why I'm so excited to talk to you and know more about this Ellison Institute, just because it's unique.

I mean, there are other institutes, as you know, like Zuckerberg, the ARC Institute.

You know, this is kind of a worldwide trend that we're seeing where, you know, great philanthropy investments are being seen outside of government.

But none have the computing resources that are being made available, nor the ability to recruit the AI scientists that will help drive this forward.

Now, the last topic I want to get into with you today is one that is where you're really grounded in, and that's the immune response.

Yep.

Yeah.

So it's pretty darn clear now that, well, in medicine, we have nothing.

We have the white cell neutrophil to lymphocyte ratio.

What a joke.

And then on the other hand, we can do T and B cell sequencing repertoires and we can do all this stuff, right?

Autoantibody screens and the list goes on and on.